Christchurch-based pharmacy and animal healthcare firm, Ebos Group, has posted a 4.9 per cent increase in full-year profit with revenue hitting $7.6 billion after it has invested in several businesses and expanded its reach into specialty pet stores over the past two years.
The company, dual listed on the New Zealand and Australian stock exchanges, posted a 7.4 per cent increase in group revenue with underlying net profit after tax up 9.1 per cent to $138.6 million. The healthcare division had a 7.1 per cent increase in earnings before interest, tax, depreciation and amortisation.
Patrick Davies, Ebos Group CEO, said the company is benefitting from a number of significant strategic investments undertaken over recent years in both their Healthcare and Animal Care divisions which, according to him, have delivered record financial performance.
“FY17 was another significant year for the group with two major acquisitions completed and a major capital expenditure program underway,” Davies said.
Davies added in FY17, the company continued to expand their healthcare businesses with the completion of the TerryWhite Chemmart merger in the first half, and more recently the acquisition of HPS, Australia’s largest provider of outsourced pharmacy services to hospitals.
“We are confident both businesses will complement and extend the Group’s revenue and earnings streams in the future,” he said.
The company stated they are confident of further profit growth into FY18 on an underlying, constant currency basis.
